About

Aravinda de Silva’s research focuses on flaviviruses, particularly dengue, a mosquito-borne virus that, according to the World Health Organization, is “spreading explosively” in many parts of the world. Currently, more than half of the world’s population is at risk of infection by one or more of the four types of dengue, which can cause serious illness or a severe, life-threatening disease known as dengue hemorrhagic fever. The de Silva laboratory studies the basic virology, human immunology, and pathogenesis of dengue. Dr. de Silva also studies Zika. He is part of a team studying the epidemiology and effective diagnostics of the maternal-fetal transmission of Zika. Dr. de Silva has received National Institutes of Health support to work on a Zika vaccine.

In the news

• 

  Researchers Awarded NIH UM2 to Advance the Science and Practice of Dissemination and Implementation Science Research in Low-to-Middle Income Countries by Adapting Evidence-Based HIV Interventions for Adolescents and Young Adults

  Suzanne Day, PhD, MA, Weiming Tang, PhD, and Joe Tucker, MD, PhD, members of the Institute for Global Health and Infectious Diseases, have been awarded an NIH UM2 cooperative grant. The project is called the”Innovative Network on the Science and Practice of Implementation, Research, and Engagement Center (INSPIRE)” and is part of a broader US … Read more

• 

  STD Awareness in April: Infectious Disease Experts Are Working to Advance the Development of Vaccines for Sexually Transmitted Infections

  During April, STD Awareness provides an opportunity to talk about STIs and encourage individuals to be proactive about their sexual health and promotes regular STI/HIV screening and testing. Although research in sexually transmitted infections (STIs) has evolved rapidly on multiple fronts, a critical remaining challenge is the development of safe and effective vaccines for diseases that pose … Read more

Education